Affirm Holdings Inc vs 22nd Century Group Inc — how do they compare? Affirm Holdings Inc trades at $73.64 (market cap $25.69B), while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: Affirm Holdings Inc is far larger — about 16901.3× 22nd Century Group Inc's market cap, and Affirm Holdings Inc is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| AFRM | XXII | |
|---|---|---|
Market Cap | $25.69B | $1.52M |
Sector | Financials | Technology |
52-Week High | $92.18 | $801.00 |
52-Week Low | $42.53 | $3.72 |
Enterprise Value | $32.30B | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
Affirm Holdings (AFRM) trades at $73.42, down 2.81% on the day, amid a bullish technical outlook and strong fundamental momentum. The stock has consistently beaten earnings expectations in recent quarters, with revenue surging from $1.3B in 2022 to $3.22B in 2025, while achieving positive net income of $52.19M after years of losses. Analyst consensus is strongly bullish with a $95.75 price target, and institutional interest remains high.
AFRM presents a compelling growth story with accelerating profitability and expanding market share in fintech, though elevated valuation multiples and sensitivity to interest rate changes pose risks. The stock's upside potential hinges on sustained execution and macroeconomic stability, making it suitable for growth-oriented investors comfortable with volatility.
XXII trades at $4.38, up 0.69% with neutral technical signals. The company shows concerning fundamentals with negative profit margins (-65.76% net income margin) and ROE of -130.19%, though valuation ratios appear low (P/S 0.03, P/B 0.07). Recent corporate actions include a 20:1 reverse stock split in June 2026. Analyst sentiment remains positive with 75% buy ratings, while the company expands VLN® product distribution in key markets like California and New York.
The outlook remains speculative given persistent losses despite revenue generation. Investment opportunity lies in successful execution of reduced-nicotine cigarette expansion and FDA regulatory progress. Key risks include continued cash burn, competitive pressures, and dependency on regulatory approvals for growth catalysts.
Trailing returns across standard periods
Latest headlines on both assets
Affirm Holdings Inc offers a platform for digital and mobile first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a major share of its revenue from the United States.
Read more on AFRM →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →